AAAAAA
Results: 51-75/282
Authors:
HAWKINS MJ
BREITMEYER JB
Citation: Mj. Hawkins et Jb. Breitmeyer, 1996 SOCIETY-FOR-BIOLOGICAL-THERAPY MEETING, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 452-455
Citation: 11TH ANNUAL-MEETING OF THE SOCIETY-FOR-BIOLOGICAL-THERAPY - OCTOBER 23-26, 1996 - WASHINGTON, DC - ABSTRACTS, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 456-468
Authors:
CONLON KC
ANVER MR
LONGO DL
ORTALDO JR
MURPHY WJ
Citation: Kc. Conlon et al., ADOPTIVE IMMUNOTHERAPY INVOLVING RECOMBINANT HUMAN M-CSF AND R24 ANTIMELANOMA ANTIBODY INDUCES HUMAN T-CELL INFILTRATION INTO HUMAN-MELANOMA XENOGRAFTS, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 317-323
Authors:
RASHID G
OPHIR R
PECHT M
LOURIE S
MESHORER A
BENEFRAIM S
TRAININ N
BURSTEIN Y
KEISARI Y
Citation: G. Rashid et al., INHIBITION OF MURINE LEWIS LUNG-CARCINOMA METASTASES BY COMBINED CHEMOTHERAPY AND INTRANASAL THF-GAMMA-2 IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 324-333
Authors:
SIESJO P
VISSE E
SJOGREN HO
Citation: P. Siesjo et al., CURE OF ESTABLISHED, INTRACEREBRAL RAT GLIOMAS INDUCED BY THERAPEUTICIMMUNIZATIONS WITH TUMOR-CELLS AND PURIFIED APC OR ADJUVANT IFN-GAMMATREATMENT, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 334-345
Authors:
HOOIJBERG E
VISSEREN MJW
VANDENBERK PCM
JELLEMA AP
ROMEIJN P
SEIN JJ
VANDERVOORT EIH
HEKMAN A
OSSENDORP F
MELIEF CJM
Citation: E. Hooijberg et al., LYSIS OF SYNGENEIC TUMOR B-CELLS BY AUTOREACTIVE CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR A CD19 ANTIGEN-DERIVED SYNTHETIC PEPTIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 346-356
Authors:
PLAYER MA
BARRACCHINI KC
SIMONIS TB
RIVOLTINI L
ARIENTI F
CASTELLI C
MAZZOCCHI A
BELLI F
PARMIANI G
MARINCOLA FM
Citation: Ma. Player et al., DIFFERENCES IN FREQUENCY-DISTRIBUTION OF HLA-A2 SUBTYPES BETWEEN NORTH-AMERICAN AND ITALIAN WHITE MELANOMA PATIENTS - RELEVANCE FOR EPITOPE-SPECIFIC VACCINATION PROTOCOLS, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 357-363
Authors:
FENTON RG
STEIS RG
MADARA K
ZEA AH
OCHOA AC
JANIK JE
SMITH JW
GAUSE BL
SHARFMAN WH
URBA WJ
HANNA MG
DEJAGER RL
COYNE MX
CROUCH RD
GRAY P
BEVERIDGE J
CREEKMORE SP
HOLMLUND J
CURTI BD
SZNOL M
LONGO DL
Citation: Rg. Fenton et al., A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 364-374
Authors:
SCHEIBENBOGEN C
WEYERS I
RUITER D
WILLHAUCK M
BITTINGER A
KEILHOLZ U
Citation: C. Scheibenbogen et al., EXPRESSION OF GP100 IN MELANOMA METASTASES RESECTED BEFORE OR AFTER TREATMENT WITH IFN-ALPHA AND IL-2, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 375-380
Authors:
LEE JE
REVEILLE JD
PLATSOUCAS CD
Citation: Je. Lee et al., ASSOCIATION OF HLA-DQB1-ASTERISK-0301 WITH MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 381-383
Authors:
MARINCOLA FM
Citation: Fm. Marincola, POSSIBLE BIASES IN REFERRAL PATTERN TO NIH AND THEIR EFFECT ON HLA ASSOCIATION STUDIES, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 384-385
Authors:
WOJTOWICZPRAGA S
VERMA UN
WAKEFIELD L
ESTEBAN JM
HARTMANN D
MAZUMDER A
Citation: S. Wojtowiczpraga et al., MODULATION OF B16 MELANOMA GROWTH AND METASTASIS BY ANTI-TRANSFORMINGGROWTH-FACTOR-BETA ANTIBODY AND INTERLEUKIN-2 (VOL 3, PG 169, 1996), Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 386-386
Authors:
VELDERS MP
VANRHIJN CM
CORNELISSEN IMHA
VANMUIJEN GNP
BRIAIRE IH
DOHLSTEN M
FLEUREN GJ
WARNAAR SO
LITVINOV SV
Citation: Mp. Velders et al., THE ROLE OF MONOCLONAL-ANTIBODY AFFINITY IN TUMOR-IMMUNOTHERAPY EVALUATED IN IN-VIVO MODELS FOR MINIMAL RESIDUAL DISEASE, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 245-256
Authors:
LUSSOW AR
BUELOW R
FANGET L
PERETTO S
GAO L
POULETTY P
Citation: Ar. Lussow et al., REDIRECTING CIRCULATING ANTIBODIES VIA LIGAND-HAPTEN CONJUGATES ELIMINATES TARGET-CELLS IN-VIVO, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 257-265
Authors:
MARINCOLA FM
RIVOLTINI L
SALGALLER ML
PLAYER T
ROSENBERG SA
Citation: Fm. Marincola et al., DIFFERENTIAL ANTI-MART-1 MELANA CTL ACTIVITY IN PERIPHERAL-BLOOD OF HLA-A2 MELANOMA PATIENTS IN COMPARISON TO HEALTHY DONORS - EVIDENCE OF IN-VIVO PRIMING BY TUMOR-CELLS/, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 266-277
Authors:
ALBERTINI MR
GAN J
JAEGER P
HANK JA
STORER B
SCHELL K
RIVEST T
SURFUS J
REISFELD RA
SCHILLER JH
SONDEL PM
Citation: Mr. Albertini et al., SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 278-295
Authors:
CURTI BD
OCHOA AC
URBA WJ
ALVORD WG
KOPP WC
POWERS G
HAWK C
CREEKMORE SP
GAUSE BL
JANIK JE
HOLMLUND JT
KREMERS P
FENTON RG
MILLER L
SZNOL S
SMITH JW
SHARFMAN WH
LONGO DL
Citation: Bd. Curti et al., INFLUENCE OF INTERLEUKIN-2 REGIMENS ON CIRCULATING POPULATIONS OF LYMPHOCYTES AFTER ADOPTIVE TRANSFER OF ANTI-CD3-STIMULATED T-CELLS - RESULTS FROM A PHASE-I TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 296-308
Authors:
MACLEAN GD
MILES DW
RUBENS RD
REDDISH MA
LONGENECKER BM
Citation: Gd. Maclean et al., ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 309-316
Authors:
WOJTOWICZPRAGA S
VERMA UM
WAKEFIELD L
ESTEBAN JM
HARTMANN D
MAZUMDER A
Citation: S. Wojtowiczpraga et al., MODULATION OF B16 MELANOMA GROWTH AND METASTASIS BY ANTI-TRANSFORMINGGROWTH-FACTOR-BETA ANTIBODY AND INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 169-175
Authors:
JAFFEE EM
THOMAS MC
HUANG AYC
HAUDA KM
LEVITSKY HI
PARDOLL DM
Citation: Em. Jaffee et al., ENHANCED IMMUNE PRIMING WITH SPATIAL-DISTRIBUTION OF PARACRINE CYTOKINE VACCINES, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 176-183
Authors:
SURFUS JE
HANK JA
OOSTERWIJK E
WELT S
LINDSTROM MJ
ALBERTINI MR
SCHILLER JH
SONDEL PM
Citation: Je. Surfus et al., ANTI-RENAL-CELL CARCINOMA CHIMERIC ANTIBODY G250 FACILITATES ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY WITH IN-VITRO AND IN-VIVO INTERLEUKIN-2-ACTIVATED EFFECTORS, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 184-191
Authors:
MARINCOLA FM
HIJAZI YM
FETSCH P
SALGALLER ML
RIVOLTINI L
CORMIER J
SIMONIS TB
DURAY PH
HERLYN M
KAWAKAMI Y
ROSENBERG SA
Citation: Fm. Marincola et al., ANALYSIS OF EXPRESSION OF THE MELANOMA-ASSOCIATED ANTIGENS MART-1 ANDGP100 IN METASTATIC MELANOMA CELL-LINES AND IN IN-SITU LESIONS, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 192-205
Authors:
MURRAY JL
KLEINERMAN ES
JIA SF
ROSENBLUM MG
ETON O
BUZAID A
LEGHA S
ROSS MI
THOMPSON L
MUJOO K
RIEGER PT
SALEH M
KHAZAELI MB
VADHANRAJ S
Citation: Jl. Murray et al., PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 206-217
Authors:
HARUTA I
YAMAUCHI K
ARUGA A
KOMATSU T
TAKASAKI K
HAYASHI N
HANYU F
Citation: I. Haruta et al., ANALYTICAL STUDY OF THE CLINICAL-RESPONSE TO 2 DISTINCT ADOPTIVE IMMUNOTHERAPIES FOR ADVANCED HEPATOCELLULAR-CARCINOMA - COMPARISON BETWEENLAK CELL AND CTL THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 218-223
Authors:
MELIOLI G
RATTO GB
PONTE M
GUASTELLA M
SEMINO C
FANTINO G
TASSARA E
PASQUETTI W
MEREU C
MERLO F
REGGIARDO G
MORASSO G
SANTI L
MORETTA L
Citation: G. Melioli et al., TREATMENT OF STAGE IIIB NON-SMALL-CELL LUNG-CANCER WITH SURGERY FOLLOWED BY INFUSION OF TUMOR-INFILTRATING LYMPHOCYTES AND RECOMBINANT INTERLEUKIN-2 - A PILOT-STUDY, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 224-230